All lobbying filings
SOLUGEN INC
SOLUGEN INC filed a Q2 report for SOLUGEN INC on July 19, 2026.
Lobbying for SOLUGEN INC · Industrial Biomanufacturing
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Expenses
$170,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Texas
Government bodies contacted
4
Lobbying activity
2
Support the use of bio-based chemicals in the Department of Defense, generally. Department of Defense Appropriations Act for Fiscal Year 2027. National Defense Authorization Act for Fiscal Year 2027.
Educate policymakers about Solugen's technology to produce bio-based chemicals, generally.